Advanced Search

 

Study ID Status Title Patient Level Data
SND 103285 Completed A Ten-Week, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Flexible-Dose Study Evaluating the Efficacy, Safety, and Tolerability of GSK372475 (1.5 mg/day to 2.0 mg/day) or Extended Release Venlafaxine XR (150 mg/day to 225 mg/day) Compared to Placebo in adult s
SND 103288 Completed A Ten-week, Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled, Paralleled-Group, Flexible-Dose study Evaluating the Efficacy, Safety and Tolerability of GSK372475 or Paroxetine Compared to Placebo in Adult Subjects Diagnosed with Major Depressive Disorder
SND103929 Completed An outpatient, randomised, double-blind, placebo controlled, parallel group exploratory study to evaluate safety, tolerability and efficacy of GW679769 in patients with Fibromyalgia Syndrome comorbid with depression.
SND110117 Completed An open label, randomized, parallel groups, bioequivalence study to compare a single oral dose of GSK372475B or GSK372475C in male and female healthy volunteers.
SPE111154 Completed A single blind, randomised, placebo controlled, single ascending dose study to evaluate the safety, tolerability and pharmacokinetics of GSK958108 in healthy male subjects
S-RHS00289 Completed An Open-Label, Single-Dose and Multi-Dose Pharmacokinetic Study of 2mg and 4mg Nicotine Lozenge in Chinese Smokers
STA106711 Completed Clinical Evaluation of Sumatriptan Succinate Injection Kit Product in Patients with Migraine or Cluster Headache
STQ105938 Completed A Phase II, multi-centre, open-label, randomised study to evaluate the safety, tolerability and pharmacokinetics of oral sitamaquine compared with amphotericin B in the treatment of visceral leishmaniasis caused by L. donovani in endemic areas.
T3157503 Completed Comparison of the clinical efficacy from the retention phase of fluoride delivery of fluoride toothpastes using an in situ caries model
T3158587 Completed A Study to Measure the Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride Using an In Situ Caries Model
T3450803 Withdrawn Clinical efficacy of an experimental toothpaste
T3500690 Completed Comparison of enamel remineralization potential of dentifrices incorporating different fluoride salts using an in situ caries model
T3508565 Completed Clinical efficacy of fluoride toothpastes using an in situ caries model
T3508570 Completed Evaluation of plaque fluid fluoride retention from fluoride toothpastes
T3508605 Completed Clinical efficacy of fluoride toothpastes using an in situ caries model
TDC106220 Completed A Phase II, 28-Day, Randomized, Parallel-Group, Open-Label Study Evaluating the Efficacy and Safety of Twice Daily Oral Doses of Testosterone (150-400mg) Co-administered with 0.25mg Dutasteride Compared with 400mg Testosterone Alone and 0.25mg Dutasteride Alone in the Treatment of Hypogonadism
TDC106222 Completed An open label study to evaluate the impact of novel fixed-dose testosterone/dutasteride combinations on the relative bioavailability of the individual dutasteride and testosterone components
TMT106386 Completed A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, fMRI and PET Study Comparing Emotional Challenge-induced Regional Cerebral Blood Flow Changes Before and After 8 Weeks of Treatment With Placebo and Paroxetine in Subjects with Social Anxiety Disorder Study Listed on ClinicalStudyDataRequest.com
TMT106468 Completed A 12 week, randomised, double blind study evaluating the effects of low dose (10mg) and high dose (80mg) atorvastatin on macrophage activity and carotid plaque inflammation as determined by Ultra small Super-Paramagnetic Iron Oxide (USPIO) enhanced carotid Magnetic Resonance Imaging (MRI)
TMT106512 Completed Dopamine D2/D3 receptor agonist and antagonist drug effects on fronto-striatal systems related to compulsive behaviour in healthy volunteers and patients with addictive and compulsive disorders
TOC100224 Completed An observer-blind, Multicenter, Non-inferiority, Comparative Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Fusidic acid cream Applied Three Times daily for 7 days in the Treatment adult and paediatric subjects with Impetigo Study Listed on ClinicalStudyDataRequest.com
TOC103469 Completed A Randomised, Double-blind, Multicentre, Superiority Placebo-controlled, Phase III Study to Assess the Efficacy and Safety of Topical 1% SB-275833 Ointment versus Placebo Ointment Applied Twice Daily for 5 days in the Treatment of Adults and Paediatric Subjects with Impetigo. Study Listed on ClinicalStudyDataRequest.com
TOC106489 Completed An Open-Label, Non-Comparative Study to Assess the Pharmacokinetics, Safety and Efficacy of Topical Retapamulin (SB-275833) Ointment, 1%, Twice Daily for Five Days in the Treatment of Uncomplicated Skin and Skin Structure Infections in Pediatric Subjects Aged 2 to 24 Months Study Listed on ClinicalStudyDataRequest.com
TOC110977 Completed A Randomized, Double-Blind, Multicenter, Placebo-controlled, Phase III Superiority Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, versus Placebo Ointment Applied Twice Daily for 5 Days in the Treatment of Adult and Pediatric Subjects with SITL Study Listed on ClinicalStudyDataRequest.com
TPD102031 Completed A Randomised, Single-Blind, Dose-Rising Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Ten Day Repeat Topical Applications of GW842470X cream on the Skin of Patients with Atopic Dermatitis

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.